View More Recent Stories
-
NeuroPace (NPCE) Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy
-
NeuroPace (NPCE) Appoints Amy Treadwell as VP of HR
-
NeuroPace (NPCE) Announces Two Management Appointments
-
NeuroPace Inc (NPCE) PT Lowered to $14 at Wolfe Research
-
NeuroPace (NPCE) Tops Q2 EPS by 4c, Beats on Revenue; Offers FY24 Revenue Guidance
